Examines the federal requirement for private insurers to cover PrEP without cost-sharing, state actions to comply, transparency issues, and next steps for enforcing the requirement.
Discusses new requirement for private insurers to cover PrEP without cost-sharing, an early analysis of insurer compliance, and the need for federal and state enforcement.
Provides an overview of historic and current federal efforts to end HIV in the US, including HIV strategic plans and the Ending the HIV Epidemic initiative, and discusses prospects of future efforts under the Biden administration and the 117th Congress.
Looks at the future of healthcare under the Biden administration and the 117th Congress, featuring discussion with Carl Schmid, Senator Bill Cassidy, Lauren Underwood, and healthcare officials.
Provides details on how insurers’ treatment of manufacturer copay assistance affects patients’ out-of-pocket spending and how high costs drive up prescription abandonment rates, especially while patients deal with the economic effects of COVID.